Human Genome Sciences Inc. (HGSI) Reports Q1 EPS Loss of $0.69
Tweet Send to a FriendGet Alerts HGSI Hot Sheet
Price: $14.24 --0%
Revenue Growth %: +77.1%
Financial Fact:
Manufacturing and development services: 15.49M
Today's EPS Names:
LBIX, ESEA, ISS, More
Revenue Growth %: +77.1%
Financial Fact:
Manufacturing and development services: 15.49M
Today's EPS Names:
LBIX, ESEA, ISS, More
Trade HGSI Now!
Human Genome Sciences Inc. (NASDAQ: HGSI) reported Q1 EPS of ($0.69), $0.21 worse than the analyst estimate of ($0.48). Revenue for the quarter came in at $26.6 million versus the consensus estimate of $19.26 million.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
You May Also Be Interested In
- UPDATE: Applied Materials, Inc. (AMAT) Tops Q2 EPS by 3c, Offers Guidance
- UPDATE: Aruba Networks, Inc. (ARUN) Misses Q3 EPS by 4c, Guidance Light
- Stage Stores, Inc. (SSI) Posts Surprise Q1 Loss of 2c/Share
Create E-mail Alert Related Categories
Earnings
Login with Facebook
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
